The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Chlorpheniramine maleate 4mg
Chlorpheniramine maleate 4mg · CHLORPHENIRAMINE MALEATE 4 mg/1 · Tablet, Coated · Oral · Athlete's Needs, Inc.
NDC 53185-0277-24 · 24 TABLET, COATED in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedOct 21, 2024BLI International, Inc. — Superpotent Drug: Stability failure for assay at 6 months test time-point.
Manufacturers of Chlorpheniramine maleate 4mg (Tablet, Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Athlete's Needs, Inc. | CHLORPHENIRAMINE MALEATE 4 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Chlorpheniramine maleate 4mg — NDC 53185-0277-24," retrieved September 3, 2026, https://drugdashboards.com/drug/53185027724.
Free to cite with attribution — see how the data is put together.